Advertisement

Lymphohematopoietic Malignancies

  • Anneclaire J. De RoosEmail author
  • Parveen Bhatti
Chapter

Abstract

Lymphohematopoietic malignancies, which include lymphomas, leukemias, and multiple myeloma, encompass a heterogeneous, but related, group of cancers that, collectively, are among the top 5 or 6 most common cancers in women and men worldwide. The incidence rate increased dramatically during the latter half of the twentieth century in the USA, Europe, and other developed regions, and the causes of this dramatic increase remain unidentified. The lymphohematopoietic system appears to be vulnerable to neoplastic changes from a variety of occupational exposures. Accepted causes of lymphohematopoietic cancers are limited at this time to benzene, 1,3-butadiene, and ionizing radiation for myeloid cell leukemias. Probable causes for at least certain lymphohematopoietic cancer subtypes, that are as yet debated, are formaldehyde, ethylene oxide, certain pesticides, animal exposures, and trichloroethylene and other solvents.

Keywords

Lymphoma Leukemia Benzene 1,3-Butadiene Ionizing radiation Formaldehyde Ethylene oxide Pesticides Animal exposures Trichloroethylene Solvents 

References

  1. 1.
    GLOBOCAN 2008. World Health Organization.Google Scholar
  2. 2.
    Devesa SS, Fears T. Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res. 1992;52:5432s–40.PubMedGoogle Scholar
  3. 3.
    Rabkin CS, Devesa SS, Zahm SH, Gail MH. Increasing incidence of non-Hodgkin’s lymphoma. Semin Hematol. 1993;30:286–96.PubMedGoogle Scholar
  4. 4.
    Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin’s lymphoma incidence. Cancer Res. 1992;52:5566s–9.PubMedGoogle Scholar
  5. 5.
    Surveillance, Epidemiology, and End Results (SEER) Program. www.seer.cancer.gov. SEER*Stat Database: incidence – SEER 9 Regs research data, Nov 2009 sub (1973–2007) <Katrina/Rita Population Adjustment> – linked to county attributes – total U.S., 1969–2007 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the Nov 2009 submission; 2010.
  6. 6.
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999;10:1419–32.PubMedGoogle Scholar
  7. 7.
    Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, editors. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.Google Scholar
  8. 8.
    Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol. 2000;12:383–94.PubMedGoogle Scholar
  9. 9.
    Hoover RN. Lymphoma risks in populations with altered immunity – a search for mechanism. Cancer Res. 1992;52:5477s–8.PubMedGoogle Scholar
  10. 10.
    Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L. Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer. 1995;60:183–9.PubMedGoogle Scholar
  11. 11.
    Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger Jr TA. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med. 1987;83:1–9.PubMedGoogle Scholar
  12. 12.
    Ekstrom K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, Askling J. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003;48:963–70.PubMedGoogle Scholar
  13. 13.
    Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni Jr JF. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993;85:307–11.PubMedGoogle Scholar
  14. 14.
    Hakulinen T, Isomaki H, Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med. 1985;78:29–32.PubMedGoogle Scholar
  15. 15.
    Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer. 1996;32A:1753–7.PubMedGoogle Scholar
  16. 16.
    Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978;89:888–92.PubMedGoogle Scholar
  17. 17.
    Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A. A longitudinal cohort study of Finnish patients with primary Sjogren’s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis. 2001;60:467–72.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Tennis P, Andrews E, Bombardier C, Wang Y, Strand L, West R, Tilson H, Doi P. Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada. J Clin Epidemiol. 1993;46:685–95.PubMedGoogle Scholar
  19. 19.
    Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S, Gridley G, Severson RK, Hartge P. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin’s lymphoma: a case-control study. Am J Epidemiol. 2005;162:1153–61.PubMedGoogle Scholar
  20. 20.
    Soderberg KC, Jonsson F, Winqvist O, Hagmar L, Feychting M. Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. Eur J Cancer. 2006;42:3028–33.PubMedGoogle Scholar
  21. 21.
    Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis Rheum. 1996;39:1050–4.PubMedGoogle Scholar
  22. 22.
    Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol. 2002;31:66–71.PubMedGoogle Scholar
  23. 23.
    Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis. 1992;51:437–9.PubMedCentralPubMedGoogle Scholar
  24. 24.
    Hannuksela-Svahn A, Pukkala E, Laara E, Poikolainen K, Karvonen J. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol. 2000;114:587–90.PubMedGoogle Scholar
  25. 25.
    Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol. 2003;139:1425–9.PubMedGoogle Scholar
  26. 26.
    Kroll ME, Murphy F, Pirie K, Reeves GK, Green J, Beral V. Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study. Br J Cancer. 2012;107:879–87.PubMedCentralPubMedGoogle Scholar
  27. 27.
    Ma X, Lim U, Park Y, Mayne ST, Wang R, Hartge P, Hollenbeck AR, Schatzkin A. Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort. Am J Epidemiol. 2009;169:1492–9.PubMedCentralPubMedGoogle Scholar
  28. 28.
    Musselman JR, Blair CK, Cerhan JR, Nguyen P, Hirsch B, Ross JA. Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation. Cancer Epidemiol. 2013;37(4):410–6.PubMedGoogle Scholar
  29. 29.
    Kabat GC, Wu JW, Moore SC, Morton LM, Park Y, Hollenbeck AR, Rohan TE. Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study. Cancer Epidemiol Biomarkers Prev. 2013;22:848–54.PubMedGoogle Scholar
  30. 30.
    Lichtman MA. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist. 2010;15:1083–101.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Larsson SC, Wolk A. Obesity and risk of non-Hodgkin’s lymphoma: a meta-analysis. Int J Cancer. 2007;121:1564–70.PubMedGoogle Scholar
  32. 32.
    Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, Boffetta P, Bracci P, Cerhan J, Chiu BC, Cocco P, Dal Maso L, Davis S, De Sanjose S, Smedby KE, Ennas MG, Foretova L, Holly EA, La Vecchia C, Matsuo K, Maynadie M, Melbye M, Negri E, Nieters A, Severson R, Slager SL, Spinelli JJ, Staines A, Talamini R, Vornanen M, Weisenburger DD, Roman E. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer. 2008;122:2062–70.PubMedCentralPubMedGoogle Scholar
  33. 33.
    Lu Y, Wang SS, Reynolds P, Chang ET, Ma H, Sullivan-Halley J, Clarke CA, Bernstein L. Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study. Am J Epidemiol. 2011;174:563–73.PubMedCentralPubMedGoogle Scholar
  34. 34.
    Diver WR, Patel AV, Thun MJ, Teras LR, Gapstur SM. The association between cigarette smoking and non-Hodgkin lymphoid neoplasms in a large US cohort study. Cancer Causes Control. 2012;23:1231–40.PubMedGoogle Scholar
  35. 35.
    Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, Stagnaro E, Willett EV, Dal Maso L, Serraino D, Chang ET, Cozen W, Davis S, Severson RK, Bernstein L, Mayne ST, Dee FR, Cerhan JR, Hartge P. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol. 2005;6:469–76.PubMedGoogle Scholar
  36. 36.
    Descatha A, Jenabian A, Conso F, Ameille J. Occupational exposures and haematological malignancies: overview on human recent data. Cancer Causes Control. 2005;16:939–53.PubMedGoogle Scholar
  37. 37.
    Hartge P, Wang SS, Bracci PM, Devesa SS, Holly EA. Non-Hodgkin lymphoma. In: Schottenfeld D, Fraumeni Jr JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. p. 898–918.Google Scholar
  38. 38.
    Blair A, Freeman LB. Epidemiologic studies in agricultural populations: observations and future directions. J Agromedicine. 2009;14:125–31.PubMedCentralPubMedGoogle Scholar
  39. 39.
    Blair A, Zahm SH, Pearce NE, Heineman EF, Fraumeni JFJ. Clues to cancer etiology from studies of farmers. Scand J Work Environ Health. 1992;18:209–15.PubMedGoogle Scholar
  40. 40.
    Keller-Byrne JE, Khuder SA, Schaub EA. Meta-analysis of leukemia and farming. Environ Res. 1995;71:1–10.PubMedGoogle Scholar
  41. 41.
    Khuder SA, Mutgi AB. Meta-analyses of multiple myeloma and farming. Am J Ind Med. 1997;32:510–6.PubMedGoogle Scholar
  42. 42.
    Acquavella J, Olsen G, Cole P, Ireland B, Kaneene J, Schuman S, Holden L. Cancer among farmers: a meta-analysis. Ann Epidemiol. 1998;8:64–74.PubMedGoogle Scholar
  43. 43.
    Khuder SA, Schaub EA, Keller-Byrne JE. Meta-analyses of non-Hodgkin’s lymphoma and farming. Scand J Work Environ Health. 1998;24:255–61.PubMedGoogle Scholar
  44. 44.
    Khuder SA, Mutgi AB, Schaub EA, Tano BD. Meta-analysis of Hodgkin’s disease among farmers. Scand J Work Environ Health. 1999;25:436–41.PubMedGoogle Scholar
  45. 45.
    Merhi M, Raynal H, Cahuzac E, Vinson F, Cravedi JP, Gamet-Payrastre L. Occupational exposure to pesticides and risk of hematopoietic cancers: meta-analysis of case-control studies. Cancer Causes Control. 2007;18:1209–26.PubMedGoogle Scholar
  46. 46.
    Van Maele-Fabry G, Duhayon S, Mertens C, Lison D. Risk of leukaemia among pesticide manufacturing workers: a review and meta-analysis of cohort studies. Environ Res. 2008;106:121–37.PubMedGoogle Scholar
  47. 47.
    Van Maele-Fabry G, Duhayon S, Lison D. A systematic review of myeloid leukemias and occupational pesticide exposure. Cancer Causes Control. 2007;18:457–78.PubMedGoogle Scholar
  48. 48.
    McDuffie HH, Pahwa P, Spinelli JJ, McLaughlin JR, Fincham S, Robson D, Dosman JA, Hu J. Canadian male farm residents, pesticide safety handling practices, exposure to animals and non-Hodgkin’s lymphoma (NHL). Am J Ind Med. 2002;Suppl 2:54–61.PubMedGoogle Scholar
  49. 49.
    Hardell L, Eriksson M, Nordstrom M. Exposure to pesticides as risk factor for non-Hodgkin’s lymphoma and hairy cell leukemia: pooled analysis of two Swedish case-control studies. Leuk Lymphoma. 2002;43:1043–9.PubMedGoogle Scholar
  50. 50.
    De Roos AJ, Zahm SH, Cantor KP, Weisenburger DD, Holmes FF, Burmeister LF, Blair A. Integrative assessment of multiple pesticides as risk factors for non-Hodgkin’s lymphoma among men. Occup Environ Med. 2003;60:E11.PubMedCentralPubMedGoogle Scholar
  51. 51.
    Miligi L, Costantini AS, Veraldi A, Benvenuti A, Vineis P. Cancer and pesticides: an overview and some results of the Italian multicenter case-control study on hematolymphopoietic malignancies. Ann N Y Acad Sci. 2006;1076:366–77.PubMedGoogle Scholar
  52. 52.
    Miligi L, Costantini AS, Bolejack V, Veraldi A, Benvenuti A, Nanni O, Ramazzotti V, Tumino R, Stagnaro E, Rodella S, Fontana A, Vindigni C, Vineis P. Non-Hodgkin’s lymphoma, leukemia, and exposures in agriculture: results from the Italian multicenter case-control study. Am J Ind Med. 2003;44:627–36.PubMedGoogle Scholar
  53. 53.
    Fritschi L, Benke G, Hughes AM, Kricker A, Turner J, Vajdic CM, Grulich A, Milliken S, Kaldor J, Armstrong BK. Occupational exposure to pesticides and risk of non-Hodgkin’s lymphoma. Am J Epidemiol. 2005;162:849–57.PubMedGoogle Scholar
  54. 54.
    Mills PK, Yang R, Riordan D. Lymphohematopoietic cancers in the United Farm Workers of America (UFW), 1988–2001. Cancer Causes Control. 2005;16:823–30.PubMedGoogle Scholar
  55. 55.
    Eriksson M, Hardell L, Carlberg M, Akerman M. Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis. Int J Cancer. 2008;123:1657–63.PubMedGoogle Scholar
  56. 56.
    Orsi L, Delabre L, Monnereau A, Delval P, Berthou C, Fenaux P, Marit G, Soubeyran P, Huguet F, Milpied N, Leporrier M, Hemon D, Troussard X, Clavel J. Occupational exposure to pesticides and lymphoid neoplasms among men: results of a French case-control study. Occup Environ Med. 2009;66:291–8.PubMedCentralPubMedGoogle Scholar
  57. 57.
    Koutros S, Alavanja MCR, Lubin JH, Sandler DP, Hoppin JA, Lynch CF, Knott C, Blair A, Freeman LEB. An update of cancer incidence in the Agricultural Health Study. J Occup Environ Med. 2010;52:1098–105.PubMedCentralPubMedGoogle Scholar
  58. 58.
    Beane Freeman LE, Rusiecki JA, Hoppin JA, Lubin JH, Koutros S, Andreotti G, Zahm SH, Hines CJ, Coble JB, Barone-Adesi F, Sloan J, Sandler DP, Blair A, Alavanja MC. Atrazine and cancer incidence among pesticide applicators in the Agricultural Health Study (1994-2007). Environ Health Perspect. 2011;119(9):1253–9.Google Scholar
  59. 59.
    Bonner MR, Lee WJ, Sandler DP, Hoppin JA, Dosemeci M, Alavanja MC. Occupational exposure to carbofuran and the incidence of cancer in the Agricultural Health Study. Environ Health Perspect. 2005;113:285–9.PubMedCentralPubMedGoogle Scholar
  60. 60.
    Bonner MR, Coble J, Blair A, Beane Freeman LE, Hoppin JA, Sandler DP, Alavanja MC. Malathion exposure and the incidence of cancer in the Agricultural Health Study. Am J Epidemiol. 2007;166:1023–34.PubMedGoogle Scholar
  61. 61.
    Bonner MR, Williams BA, Rusiecki JA, Blair A, Beane Freeman LE, Hoppin JA, Dosemeci M, Lubin J, Sandler DP, Alavanja MC. Occupational exposure to terbufos and the incidence of cancer in the Agricultural Health Study. Cancer Causes Control. 2010;21:871–7.PubMedCentralPubMedGoogle Scholar
  62. 62.
    Christensen CH, Platz EA, Andreotti G, Blair A, Hoppin JA, Koutros S, Lynch CF, Sandler DP, Alavanja MC. Coumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS). Environ Health Perspect. 2010;118:92–6.PubMedCentralPubMedGoogle Scholar
  63. 63.
    De Roos AJ, Blair A, Rusiecki JA, Hoppin JA, Svec M, Dosemeci M, Sandler DP, Alavanja MC. Cancer incidence among glyphosate-exposed pesticide applicators in the Agricultural Health Study. Environ Health Perspect. 2005;113:49–54.PubMedCentralPubMedGoogle Scholar
  64. 64.
    Delancey JO, Alavanja MC, Coble J, Blair A, Hoppin JA, Austin HD, Beane Freeman LE. Occupational exposure to metribuzin and the incidence of cancer in the Agricultural Health Study. Ann Epidemiol. 2009;19:388–95.PubMedCentralPubMedGoogle Scholar
  65. 65.
    Hou L, Lee WJ, Rusiecki J, Hoppin JA, Blair A, Bonner MR, Lubin JH, Samanic C, Sandler DP, Dosemeci M, Alavanja MC. Pendimethalin exposure and cancer incidence among pesticide applicators. Epidemiology. 2006;17:302–7.PubMedCentralPubMedGoogle Scholar
  66. 66.
    Kang D, Park SK, Beane-Freeman L, Lynch CF, Knott CE, Sandler DP, Hoppin JA, Dosemeci M, Coble J, Lubin J, Blair A, Alavanja M. Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study. Environ Res. 2008;107:271–6.PubMedGoogle Scholar
  67. 67.
    Koutros S, Mahajan R, Zheng T, Hoppin JA, Ma X, Lynch CF, Blair A, Alavanja MC. Dichlorvos exposure and human cancer risk: results from the Agricultural Health Study. Cancer Causes Control. 2008;19:59–65.PubMedCentralPubMedGoogle Scholar
  68. 68.
    Lee WJ, Blair A, Hoppin JA, Lubin JH, Rusiecki JA, Sandler DP, Dosemeci M, Alavanja MC. Cancer incidence among pesticide applicators exposed to chlorpyrifos in the Agricultural Health Study. J Natl Cancer Inst. 2004;96:1781–9.PubMedGoogle Scholar
  69. 69.
    Lee WJ, Hoppin JA, Blair A, Lubin JH, Dosemeci M, Sandler DP, Alavanja MC. Cancer incidence among pesticide applicators exposed to alachlor in the Agricultural Health Study. Am J Epidemiol. 2004;159:373–80.PubMedGoogle Scholar
  70. 70.
    Lee WJ, Alavanja MC, Hoppin JA, Rusiecki JA, Kamel F, Blair A, Sandler DP. Mortality among pesticide applicators exposed to chlorpyrifos in the Agricultural Health Study. Environ Health Perspect. 2007;115:528–34.PubMedCentralPubMedGoogle Scholar
  71. 71.
    Lynch SM, Rusiecki JA, Blair A, Dosemeci M, Lubin J, Sandler D, Hoppin JA, Lynch CF, Alavanja MC. Cancer incidence among pesticide applicators exposed to cyanazine in the Agricultural Health Study. Environ Health Perspect. 2006;114:1248–52.PubMedCentralPubMedGoogle Scholar
  72. 72.
    Lynch SM, Mahajan R, Beane Freeman LE, Hoppin JA, Alavanja MC. Cancer incidence among pesticide applicators exposed to butylate in the Agricultural Health Study (AHS). Environ Res. 2009;109:860–8.PubMedCentralPubMedGoogle Scholar
  73. 73.
    Mahajan R, Blair A, Lynch CF, Schroeder P, Hoppin JA, Sandler DP, Alavanja MC. Fonofos exposure and cancer incidence in the Agricultural Health Study. Environ Health Perspect. 2006;114:1838–42.PubMedCentralPubMedGoogle Scholar
  74. 74.
    Mahajan R, Bonner MR, Hoppin JA, Alavanja MC. Phorate exposure and incidence of cancer in the Agricultural Health Study. Environ Health Perspect. 2006;114:1205–9.PubMedCentralPubMedGoogle Scholar
  75. 75.
    Mahajan R, Blair A, Coble J, Lynch CF, Hoppin JA, Sandler DP, Alavanja MC. Carbaryl exposure and incident cancer in the Agricultural Health Study. Int J Cancer. 2007;121:1799–805.PubMedGoogle Scholar
  76. 76.
    Mozzachio AM, Rusiecki JA, Hoppin JA, Mahajan R, Patel R, Beane-Freeman L, Alavanja MC. Chlorothalonil exposure and cancer incidence among pesticide applicator participants in the Agricultural Health Study. Environ Res. 2008;108:400–3.PubMedCentralPubMedGoogle Scholar
  77. 77.
    Park SK, Kang D, Beane-Freeman L, Blair A, Hoppin JA, Sandler DP, Lynch CF, Knott C, Gwak J, Alavanja M. Cancer incidence among paraquat exposed applicators in the Agricultural Health Study: prospective cohort study. Int J Occup Environ Health. 2009;15:274–81.PubMedCentralPubMedGoogle Scholar
  78. 78.
    Purdue MP, Hoppin JA, Blair A, Dosemeci M, Alavanja MC. Occupational exposure to organochlorine insecticides and cancer incidence in the Agricultural Health Study. Int J Cancer. 2007;120:642–9.PubMedCentralPubMedGoogle Scholar
  79. 79.
    Rusiecki JA, Hou L, Lee WJ, Blair A, Dosemeci M, Lubin JH, Bonner M, Samanic C, Hoppin JA, Sandler DP, Alavanja MC. Cancer incidence among pesticide applicators exposed to metolachlor in the Agricultural Health Study. Int J Cancer. 2006;118:3118–23.PubMedGoogle Scholar
  80. 80.
    Rusiecki JA, Patel R, Koutros S, Beane-Freeman L, Landgren O, Bonner MR, Coble J, Lubin J, Blair A, Hoppin JA, Alavanja MC. Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health Study. Environ Health Perspect. 2009;117:581–6.PubMedCentralPubMedGoogle Scholar
  81. 81.
    Samanic C, Rusiecki J, Dosemeci M, Hou L, Hoppin JA, Sandler DP, Lubin J, Blair A, Alavanja MC. Cancer incidence among pesticide applicators exposed to dicamba in the Agricultural Health Study. Environ Health Perspect. 2006;114:1521–6.PubMedCentralPubMedGoogle Scholar
  82. 82.
    van Bemmel DM, Visvanathan K, Beane Freeman LE, Coble J, Hoppin JA, Alavanja MC. S-ethyl-N, N-dipropylthiocarbamate exposure and cancer incidence among male pesticide applicators in the Agricultural Health Study: a prospective cohort. Environ Health Perspect. 2008;116:1541–6.PubMedCentralPubMedGoogle Scholar
  83. 83.
    Barry KH, Koutros S, Lubin JH, Coble JB, Barone-Adesi F, Beane Freeman LE, Sandler DP, Hoppin JA, Ma X, Zheng T, Alavanja MC. Methyl bromide exposure and cancer risk in the Agricultural Health Study. Cancer Causes Control. 2012;23:807–18.PubMedCentralPubMedGoogle Scholar
  84. 84.
    Leon ME, Beane Freeman LE, Douwes J, Hoppin JA, Kromhout H, Lebailly P, Nordby KC, Schenker M, Schuz J, Waring SC, Alavanja MC, Annesi-Maesano I, Baldi I, Dalvie MA, Ferro G, Fervers B, Langseth H, London L, Lynch CF, McLaughlin J, Merchant JA, Pahwa P, Sigsgaard T, Stayner L, Wesseling C, Yoo KY, Zahm SH, Straif K, Blair A. AGRICOH: a consortium of agricultural cohorts. Int J Environ Res Public Health. 2011;8:1341–57.PubMedCentralPubMedGoogle Scholar
  85. 85.
    Weng WK, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma. 2003;44:1113–20.PubMedGoogle Scholar
  86. 86.
    McDuffie HH, Pahwa P, McLaughlin JR, Spinelli JJ, Fincham S, Dosman JA, Robson D, Skinnider LF, Choi NW. Non-Hodgkin’s lymphoma and specific pesticide exposures in men: cross- Canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev. 2001;10:1155–63.PubMedGoogle Scholar
  87. 87.
    Eriksson M, Karlsson M. Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br J Ind Med. 1992;49:95–103.PubMedCentralPubMedGoogle Scholar
  88. 88.
    Persson B, Fredrikson M. Some risk factors for non-Hodgkin’s lymphoma. Int J Occup Med Environ Health. 1999;12:135–42.PubMedGoogle Scholar
  89. 89.
    Rusiecki JA, De Roos A, Lee WJ, Dosemeci M, Lubin JH, Hoppin JA, Blair A, Alavanja MC. Cancer incidence among pesticide applicators exposed to atrazine in the Agricultural Health Study. J Natl Cancer Inst. 2004;96:1375–82.PubMedGoogle Scholar
  90. 90.
    Trejo O, Ramos-Casals M, Lopez-Guillermo A, Garcia-Carrasco M, Yague J, Cervera R, Font J, Ingelmo M. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases. Semin Arthritis Rheum. 2003;33:19–28.PubMedGoogle Scholar
  91. 91.
    Nanni O, Amadori D, Lugaresi C, Falcini F, Scarpi E, Saragoni A, Buiatti E. Chronic lymphocytic leukaemias and non-Hodgkin’s lymphomas by histological type in farming-animal breeding workers: a population case- control study based on a priori exposure matrices. Occup Environ Med. 1996;53:652–7.PubMedCentralPubMedGoogle Scholar
  92. 92.
    Beane Freeman LE, Bonner MR, Blair A, Hoppin JA, Sandler DP, Lubin JH, Dosemeci M, Lynch CF, Knott C, Alavanja MCR. Cancer incidence among male pesticide applicators in the Agricultural Health Study cohort exposed to diazinon. Am J Epidemiol. 2005;162:1070–9.PubMedGoogle Scholar
  93. 93.
    Blair A, Cantor KP, Zahm SH. Non-Hodgkin’s lymphoma and agricultural use of the insecticide lindane. Am J Ind Med. 1998;33:82–7.PubMedGoogle Scholar
  94. 94.
    De Roos AJ, Hartge P, Lubin JH, Colt JS, Davis S, Cerhan JR, Severson RK, Cozen W, Patterson Jr DG, Needham LL, Rothman N. Persistent organochlorine chemicals in plasma and risk of non-Hodgkin’s lymphoma. Cancer Res. 2005;65:11214–26.PubMedGoogle Scholar
  95. 95.
    Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsouer K, Zahm SH, Needham LL, Pearson GR, Hoover RN, Comstock GW, Strickland PT. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet. 1997;350:240–4.PubMedGoogle Scholar
  96. 96.
    Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin’s lymphoma: a report from three cohorts. Cancer Res. 2007;67:5545–52.PubMedGoogle Scholar
  97. 97.
    Spinelli JJ, Ng CH, Weber JP, Connors JM, Gascoyne RD, Lai AS, Brooks-Wilson AR, Le ND, Berry BR, Gallagher RP. Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer. 2007;121:2767–75.PubMedGoogle Scholar
  98. 98.
    Cocco P, Brennan P, Ibba A, de Sanjose LS, Maynadie M, Nieters A, Becker N, Ennas MG, Tocco MG, Boffetta P. Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes. Occup Environ Med. 2008;65:132–40.PubMedGoogle Scholar
  99. 99.
    Bertrand KA, Spiegelman D, Aster JC, Altshul LM, Korrick SA, Rodig SJ, Zhang SM, Kurth T, Laden F. Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men. Epidemiology. 2010;21:172–80.PubMedCentralPubMedGoogle Scholar
  100. 100.
    Hardell E, Eriksson M, Lindstrom G, Van Bavel B, Linde A, Carlberg M, Liljegren G. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma. Leuk Lymphoma. 2001;42:619–29.PubMedGoogle Scholar
  101. 101.
    Quintana PJ, Delfino RJ, Korrick S, Ziogas A, Kutz FW, Jones EL, Laden F, Garshick E. Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin’s lymphoma. Environ Health Perspect. 2004;112:854–61.PubMedCentralPubMedGoogle Scholar
  102. 102.
    Hardell K, Carlberg M, Hardell L, Bjornfoth H, Ericson JI, Eriksson M, Van BB, Lindstrom G. Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma. Oncol Rep. 2009;21:1567–76.PubMedGoogle Scholar
  103. 103.
    Pradier C, Carrieri MP, Piche M, Rosenthal E, Dellamonica P, Serraino D. Hepatitis C virus infection and cancer risk among HIV-infected individuals. Infection. 2003;31:194–6.PubMedGoogle Scholar
  104. 104.
    Hardell L, Eriksson M, Degerman A. Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non- Hodgkin’s lymphoma. Cancer Res. 1994;54:2386–9.PubMedGoogle Scholar
  105. 105.
    Collins JJ, Bodner K, Aylward LL, Wilken M, Swaen G, Budinsky R, Rowlands C, Bodnar CM. Mortality rates among workers exposed to dioxins in the manufacture of pentachlorophenol. J Occup Environ Med. 2009;51:1212–9.PubMedGoogle Scholar
  106. 106.
    Demers PA, Davies HW, Friesen MC, Hertzman C, Ostry A, Hershler R, Teschke K. Cancer and occupational exposure to pentachlorophenol and tetrachlorophenol (Canada). Cancer Causes Control. 2006;17:749–58.PubMedGoogle Scholar
  107. 107.
    Ruder AM, Yiin JH. Mortality of US pentachlorophenol production workers through 2005. Chemosphere. 2011;83:851–61.PubMedGoogle Scholar
  108. 108.
    Kogevinas M, Kauppinen T, Winkelmann R, Becher H, Bertazzi PA, Bueno-de-Mesquita HB, Coggon D, Green L, Johnson E, Littorin M. Soft tissue sarcoma and non-Hodgkin’s lymphoma in workers exposed to phenoxy herbicides, chlorophenols, and dioxins: two nested case-control studies. Epidemiology. 1995;6: 396–402.PubMedGoogle Scholar
  109. 109.
    Cooper GS, Jones S. Pentachlorophenol and cancer risk: focusing the lens on specific chlorophenols and contaminants. Environ Health Perspect. 2008;116:1001–8.PubMedCentralPubMedGoogle Scholar
  110. 110.
    Richardson DB, Terschüren C, Hoffmann W. Occupational risk factors for non-Hodgkin’s lymphoma: a population-based case-control study in Northern Germany. Am J Ind Med. 2008;51: 258–68.PubMedGoogle Scholar
  111. 111.
    Flodin U, Fredriksson M, Persson B. Multiple myeloma and engine exhausts, fresh wood, and creosote: a case-referent study. Am J Ind Med. 1987;12:519–29.PubMedGoogle Scholar
  112. 112.
    Chiu BC, Dave BJ, Blair A, Gapstur SM, Zahm SH, Weisenburger DD. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood. 2006;108:1363–9.PubMedCentralPubMedGoogle Scholar
  113. 113.
    Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B, Cerhan JR, Lynch CF, Schuman LM, Tolbert PE, Rothman N, Cantor KP, Blair A. Agricultural risk factors for t(14;18) subtypes of non-Hodgkin’s lymphoma. Epidemiology. 2001;12:701–9.PubMedGoogle Scholar
  114. 114.
    Svec MA, Ward MH, Dosemeci M, Checkoway H, De Roos AJ. Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public. Occup Environ Med. 2005;62:726–35.PubMedCentralPubMedGoogle Scholar
  115. 115.
    Cano MI, Pollan M. Non-Hodgkin’s lymphomas and occupation in Sweden. Int Arch Occup Environ Health. 2001;74:443–9.PubMedGoogle Scholar
  116. 116.
    Fritschi L, Johnson KC, Kliewer EV, Fry R. Animal-related occupations and the risk of leukemia, myeloma, and non- Hodgkin’s lymphoma in Canada. Cancer Causes Control. 2002;13:563–71.PubMedGoogle Scholar
  117. 117.
    Tranah GJ, Bracci PM, Holly EA. Domestic and farm-animal exposures and risk of non-Hodgkin’s lymphoma in a population-based study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev. 2008;17:2382–7.PubMedCentralPubMedGoogle Scholar
  118. 118.
    Pearce NE, Sheppard RA, Howard JK, Fraser J, Lilley BM. Leukemia among New Zealand agricultural workers. A cancer registry-based study. Am J Epidemiol. 1986;124:402–9.PubMedGoogle Scholar
  119. 119.
    Pearce NE, Smith AH, Howard JK, Sheppard RA, Giles HJ, Teague CA. Case-control study of multiple myeloma and farming. Br J Cancer. 1986;54:493–500.PubMedCentralPubMedGoogle Scholar
  120. 120.
    Nordstrom M, Hardell L, Magnuson A, Hagberg H, Rask-Andersen A. Occupational exposures, animal exposure and smoking as risk factors for hairy cell leukaemia evaluated in a case-control study. Br J Cancer. 1998;77:2048–52.PubMedGoogle Scholar
  121. 121.
    Clavel J, Mandereau L, Cordier S, Legoaster C, Hemon D, Conso F, Flandrin G. Hairy-cell leukemia, occupation, and smoking. Br J Haematol. 1995;91:154–61.PubMedGoogle Scholar
  122. 122.
    Becker N, Deeg E, Nieters A. Population-based study of lymphoma in Germany: rationale, study design and first results. Leuk Res. 2004;28:713–24.PubMedGoogle Scholar
  123. 123.
    Pearce NE, Smith AH, Fisher DO. Malignant lymphoma and multiple myeloma linked with agricultural occupations in a New Zealand Cancer Registry-based study. Am J Epidemiol. 1985;121:225–37.PubMedGoogle Scholar
  124. 124.
    Baris D, Silverman DT, Brown LM, Swanson GM, Hayes RB, Schwartz AG, Liff JM, Schoenberg JB, Pottern LM, Greenberg RS, Stewart PA. Occupation, pesticide exposure and risk of multiple myeloma. Scand J Work Environ Health. 2004;30:215–22.PubMedGoogle Scholar
  125. 125.
    Pahwa P, McDuffie HH, Dosman JA, Robson D, McLaughlin JR, Spinelli JJ, Fincham S. Exposure to animals and selected risk factors among Canadian farm residents with Hodgkin’s disease, multiple myeloma, or soft tissue sarcoma. J Occup Environ Med. 2003;45:857–68.PubMedGoogle Scholar
  126. 126.
    Johnson ES, Shorter C, Rider B, Jiles R. Mortality from cancer and other diseases in poultry slaughtering/processing plants. Int J Epidemiol. 1997;26:1142–50.PubMedGoogle Scholar
  127. 127.
    Bethwaite P, McLean D, Kennedy J, Pearce N. Adult-onset acute leukemia and employment in the meat industry: a New Zealand case-control study. Cancer Causes Control. 2001;12:635–43.PubMedGoogle Scholar
  128. 128.
    Metayer C, Johnson ES, Rice JC. Nested case-control study of tumors of the hematopoietic and lymphatic systems among workers in the meat industry. Am J Epidemiol. 1998;147:727–38.PubMedGoogle Scholar
  129. 129.
    Neasham D, Sifi A, Nielsen KR, Overvad K, Raaschou-Nielsen O, Tjonneland A, Barricarte A, Gonzalez CA, Navarro C, Rodriguez SL, Travis RC, Key T, Linseisen J, Kaaks R, Crosignani P, Berrino F, Rosso S, Mattiello A, Vermeulen RC, Bueno-de-Mesquita HB, Berglund G, Manjer J, Zackrisson S, Hallmans G, Malmer B, Bingham S, Khaw KT, Bergmann MM, Boeing H, Trichopoulou A, Masala G, Tumino R, Lund E, Slimani N, Ferrari P, Boffetta P, Vineis P, Riboli E. Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC). Occup Environ Med. 2011;68:77–81.PubMedGoogle Scholar
  130. 130.
    Tatham L, Tolbert P, Kjeldsberg C. Occupational risk factors for subgroups of non-Hodgkin’s lymphoma. Epidemiology. 1997;8:551–8.PubMedGoogle Scholar
  131. 131.
    Blair A, Hayes Jr HM. Mortality patterns among US veterinarians, 1947–1977: an expanded study. Int J Epidemiol. 1982;11:391–7.PubMedGoogle Scholar
  132. 132.
    Kinlen LJ. Mortality among British veterinary surgeons. Br Med J (Clin Res Ed). 1983;287:1017–9.Google Scholar
  133. 133.
    Sjodin A, Jones RS, Focant JF, Lapeza C, Wang RY, McGahee III EE, Zhang Y, Turner WE, Slazyk B, Needham LL, Patterson Jr DG. Retrospective time-trend study of polybrominated diphenyl ether and polybrominated and polychlorinated biphenyl levels in human serum from the United States. Environ Health Perspect. 2004;112:654–8.PubMedCentralPubMedGoogle Scholar
  134. 134.
    Patterson Jr DG, Wong LY, Turner WE, Caudill SP, Dipietro ES, McClure PC, Cash TP, Osterloh JD, Pirkle JL, Sampson EJ, Needham LL. Levels in the U.S. population of those persistent organic pollutants (2003–2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements. Environ Sci Technol. 2009;43:1211–8.PubMedGoogle Scholar
  135. 135.
    Centers for Disease Control and Prevention. Fourth National Report on Human Exposure to Environmental Chemicals. Department of Health and Human Services, 2009.Google Scholar
  136. 136.
    Moysich KB, Ambrosone CB, Vena JE, Shields PG, Mendola P, Kostyniak P, Greizerstein H, Graham S, Marshall JR, Schisterman EF, Freudenheim JL. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998;7:181–8.PubMedGoogle Scholar
  137. 137.
    Agudo A, Goni F, Etxeandia A, Vives A, Millan E, Lopez R, Amiano P, Ardanaz E, Barricarte A, Chirlaque MD, Dorronsoro M, Jakszyn P, Larranaga N, Martinez C, Navarro C, Rodriguez L, Sanchez MJ, Tormo MJ, Gonzalez CA. Polychlorinated biphenyls in Spanish adults: determinants of serum concentrations. Environ Res. 2009;109:620–8.PubMedGoogle Scholar
  138. 138.
    Cerna M, Maly M, Grabic R, Batariova A, Smid J, Benes B. Serum concentrations of indicator PCB congeners in the Czech adult population. Chemosphere. 2008;72:1124–31.PubMedGoogle Scholar
  139. 139.
    IARC Working Group on the evaluation of carcinogenic risks to humans: polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. Lyon, France, 4–11 February 1997. IARC Monogr Eval Carcinog Risks Hum 1997;69:1–631.Google Scholar
  140. 140.
    Baan R, Grosse Y, Straif K, Secretan B, El GF, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens–Part F: chemical agents and related occupations. Lancet Oncol. 2009;10:1143–4.PubMedGoogle Scholar
  141. 141.
    Consonni D, Pesatori AC, Zocchetti C, Sindaco R, D’Oro LC, Rubagotti M, Bertazzi PA. Mortality in a population exposed to dioxin after the Seveso, Italy, accident in 1976: 25 years of follow-up. Am J Epidemiol. 2008;167:847–58.PubMedGoogle Scholar
  142. 142.
    Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Fingerhut M, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N, Saracci R. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol. 1997;145:1061–75.PubMedGoogle Scholar
  143. 143.
    Viel JF, Arveux P, Baverel J, Cahn JY. Soft-tissue sarcoma and non-Hodgkin’s lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. Am J Epidemiol. 2000;152:13–9.PubMedGoogle Scholar
  144. 144.
    Van den Berg M, Birnbaum L, Bosveld AT, Brunstrom B, Cook P, Feeley M, Giesy JP, Hanberg A, Hasegawa R, Kennedy SW, Kubiak T, Larsen JC, van Leeuwen FX, Liem AK, Nolt C, Peterson RE, Poellinger L, Safe S, Schrenk D, Tillitt D, Tysklind M, Younes M, Waern F, Zacharewski T. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect. 1998;106:775–92.PubMedCentralPubMedGoogle Scholar
  145. 145.
    Ballschmiter K, Zell M. Baseline studies of the global pollution. I. Occurrence of organohalogens in pristine European and antarctic aquatic environments. Int J Environ Anal Chem. 1980;8:15–35.PubMedGoogle Scholar
  146. 146.
    Safe S. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems. Environ Health Perspect. 1993;100:259–68.PubMedCentralPubMedGoogle Scholar
  147. 147.
    Laden F, Bertrand KA, Altshul L, Aster JC, Korrick SA, Sagiv SK. Plasma organochlorine levels and risk of non-Hodgkin lymphoma in the Nurses’ Health Study. Cancer Epidemiol Biomarkers Prev. 2010;19:1381–4.PubMedCentralPubMedGoogle Scholar
  148. 148.
    Brauner EV, Sorensen M, Gaudreau E, Leblanc A, Eriksen KT, Tjonneland A, Overvad K, Raaschou-Nielsen O. A prospective study of organochlorines in adipose tissue and risk of nonHodgkin lymphoma. Environ Health Perspect. 2012;120:105–11.PubMedCentralPubMedGoogle Scholar
  149. 149.
    Bosetti C, Negri E, Fattore E, La Vecchia C. Occupational exposure to polychlorinated biphenyls and cancer risk. Eur J Cancer Prev. 2003;12:251–5.PubMedGoogle Scholar
  150. 150.
    Massoudi BL, Talbott EO, Day RD, Swerdlow SH, Marsh GM, Kuller LH. A case-control study of hematopoietic and lymphoid neoplasms: the role of work in the chemical industry. Am J Ind Med. 1997;31:21–7.PubMedGoogle Scholar
  151. 151.
    Orsi L, Troussard X, Monnereau A, Berthou C, Fenaux P, Marit G, Soubeyran P, Huguet F, Milpied N, Leporrier M, Hemon D, Clavel J. Occupation and lymphoid malignancies: results from a French case-control study. J Occup Environ Med. 2007;49:1339–50.PubMedGoogle Scholar
  152. 152.
    Gold LS, Stewart PA, Milliken K, Purdue M, Severson R, Seixas N, Blair A, Hartge P, Davis S, De Roos AJ. The relationship between multiple myeloma and occupational exposure to six chlorinated solvents. Occup Environ Med. 2011;68(6):391–9.Google Scholar
  153. 153.
    Karunanayake CP, McDuffie HH, Dosman JA, Spinelli JJ, Pahwa P. Occupational exposures and non-Hodgkin’s lymphoma: Canadian case-control study. Environ Health. 2008;7:44.PubMedCentralPubMedGoogle Scholar
  154. 154.
    Lee WJ, Baris D, Jarvholm B, Silverman DT, Bergdahl IA, Blair A. Multiple myeloma and diesel and other occupational exposures in Swedish construction workers. Int J Cancer. 2003;107:134–8.PubMedGoogle Scholar
  155. 155.
    Mester B, Nieters A, Deeg E, Elsner G, Becker N, Seidler A. Occupation and malignant lymphoma: a population based case control study in Germany. Occup Environ Med. 2006;63:17–26.PubMedCentralPubMedGoogle Scholar
  156. 156.
    Scherr PA, Hutchison GB, Neiman RS. Non-Hodgkin’s lymphoma and occupational exposure. Cancer Res. 1992;52:5503s–9.PubMedGoogle Scholar
  157. 157.
    Demers PA, Vaughan TL, Koepsell TD, Lyon JL, Swanson GM, Greenberg RS, Weiss NS. A case-control study of multiple myeloma and occupation. Am J Ind Med. 1993;23:629–39.PubMedGoogle Scholar
  158. 158.
    Bethwaite PB, Pearce N, Fraser J. Cancer risks in painters: study based on the New Zealand Cancer Registry. Br J Ind Med. 1990;47:742–6.PubMedCentralPubMedGoogle Scholar
  159. 159.
    Lundberg I, Milatou-Smith R. Mortality and cancer incidence among Swedish paint industry workers with long-term exposure to organic solvents. Scand J Work Environ Health. 1998;24: 270–5.PubMedGoogle Scholar
  160. 160.
    Costantini AS, Miligi L, Kriebel D, Ramazzotti V, Rodella S, Scarpi E, Stagnaro E, Tumino R, Fontana A, Masala G, Vigano C, Vindigni C, Crosignani P, Benvenuti A, Vineis P. A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology. 2001;12:78–87.PubMedGoogle Scholar
  161. 161.
    Morton W, Marjanovic D. Leukemia incidence by occupation in the Portland-Vancouver metropolitan area. Am J Ind Med. 1984;6:185–205.PubMedGoogle Scholar
  162. 162.
    Zheng T, Blair A, Zhang Y, Weisenburger DD, Zahm SH. Occupation and risk of non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. J Occup Environ Med. 2002;44:469–74.PubMedGoogle Scholar
  163. 163.
    Motohashi N, Nagashima H, Molnar J. Trichloroethylene. II. Mechanism of carcinogenicity of trichloroethylene. In Vivo. 1999;13:215–9.PubMedGoogle Scholar
  164. 164.
    Zhang L, Rothman N, Li G, Guo W, Yang W, Hubbard AE, Hayes RB, Yin S, Lu W, Smith MT. Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers. Environ Mol Mutagen. 2007;48:467–74.PubMedGoogle Scholar
  165. 165.
    McHale CM, Lan Q, Corso C, Li G, Zhang L, Vermeulen R, Curry JD, Shen M, Turakulov R, Higuchi R, Germer S, Yin S, Rothman N, Smith MT. Chromosome translocations in workers exposed to benzene. J Natl Cancer Inst Monogr. 2008;39:74–7.Google Scholar
  166. 166.
    Tao L, Li Y, Kramer PM, Wang W, Pereira MA. Hypomethylation of DNA and the insulin-like growth factor-II gene in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Toxicology. 2004;196:127–36.PubMedGoogle Scholar
  167. 167.
    Griffin JM, Gilbert KM, Lamps LW, Pumford NR. CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol Sci. 2000;57:345–52.PubMedGoogle Scholar
  168. 168.
    Blossom SJ, Gilbert KM. Exposure to a metabolite of the environmental toxicant, trichloroethylene, attenuates CD4+ T cell activation-induced cell death by metalloproteinase-dependent FasL shedding. Toxicol Sci. 2006;92:103–14.PubMedGoogle Scholar
  169. 169.
    Andrys C, Hanovcova I, Chylkova V, Tejral J, Eminger S, Prochazkova J. Immunological monitoring of dry-cleaning shop workers–exposure to tetrachloroethylene. Cent Eur J Public Health. 1997;5:136–42.PubMedGoogle Scholar
  170. 170.
    Golding BT, Watson WP. Possible mechanisms of carcinogenesis after exposure to benzene. IARC Sci Publ. 1999;150:75–88.Google Scholar
  171. 171.
    Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT. Hematotoxicity in workers exposed to low levels of benzene. Science. 2004;306:1774–6.PubMedCentralPubMedGoogle Scholar
  172. 172.
    Khalade A, Jaakkola MS, Pukkala E, Jaakkola JJ. Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ Health. 2010;9:31.PubMedCentralPubMedGoogle Scholar
  173. 173.
    Schnatter AR, Glass DC, Tang G, Irons RD, Rushton L. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis. J Natl Cancer Inst. 2012;104:1724–37.PubMedCentralPubMedGoogle Scholar
  174. 174.
    Weed DL. Meta-analysis and causal inference: a case study of benzene and non-Hodgkin lymphoma. Ann Epidemiol. 2010;20:347–55.PubMedGoogle Scholar
  175. 175.
    Snyder CA, Goldstein BD, Sellakumar AR, Bromberg I, Laskin S, Albert RE. The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in ARK/J and C57BL/6J mice. Toxicol Appl Pharmacol. 1980;54:323–31.PubMedGoogle Scholar
  176. 176.
    Cronkite EP. Benzene hematotoxicity and leukemogenesis. Blood Cells. 1986;12:129–37.PubMedGoogle Scholar
  177. 177.
    Huff JE, Haseman JK, DeMarini DM, Eustis S, Maronpot RR, Peters AC, Persing RL, Chrisp CE, Jacobs AC. Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. Environ Health Perspect. 1989;82:125–63.PubMedCentralPubMedGoogle Scholar
  178. 178.
    Maltoni C, Ciliberti A, Cotti G, Conti B, Belpoggi F. Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ Health Perspect. 1989;82:109–24.PubMedCentralPubMedGoogle Scholar
  179. 179.
    Farris GM, Everitt JI, Irons RD, Popp JA. Carcinogenicity of inhaled benzene in CBA mice. Fundam Appl Toxicol. 1993;20:503–7.PubMedGoogle Scholar
  180. 180.
    Kawasaki Y, Hirabayashi Y, Kaneko T, Kanno J, Kodama Y, Matsushima Y, Ogawa Y, Saitoh M, Sekita K, Uchida O, Umemura T, Yoon BI, Inoue T. Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice. Toxicol Sci. 2009;110:293–306.PubMedCentralPubMedGoogle Scholar
  181. 181.
    Forni A. Chromosome changes and benzene exposure. A review. Rev Environ Health. 1979;3:5–17.PubMedGoogle Scholar
  182. 182.
    Zhang L, Eastmond DA, Smith MT. The nature of chromosomal aberrations detected in humans exposed to benzene. Crit Rev Toxicol. 2002;32:1–42.PubMedGoogle Scholar
  183. 183.
    Sul D, Lee D, Im H, Oh E, Kim J, Lee E. Single strand DNA breaks in T- and B-lymphocytes and granulocytes in workers exposed to benzene. Toxicol Lett. 2002;134:87–95.PubMedGoogle Scholar
  184. 184.
    Alexander DD, Wagner ME. Benzene exposure and non-Hodgkin lymphoma: a meta-analysis of epidemiologic studies. J Occup Environ Med. 2010;52:169–89.PubMedGoogle Scholar
  185. 185.
    Vlaanderen J, Lan Q, Kromhout H, Rothman N, Vermeulen R. Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions. Environ Health Perspect. 2011;119:159–67.PubMedCentralPubMedGoogle Scholar
  186. 186.
    Infante PF. Benzene exposure and multiple myeloma: a detailed meta-analysis of benzene cohort studies. Ann N Y Acad Sci. 2006;1076:90–109.PubMedGoogle Scholar
  187. 187.
    Wong O, Raabe GK. Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. Regul Toxicol Pharmacol. 1997;26:188–99.PubMedGoogle Scholar
  188. 188.
    Miligi L, Costantini AS, Benvenuti A, Kriebel D, Bolejack V, Tumino R, Ramazzotti V, Rodella S, Stagnaro E, Crosignani P, Amadori D, Mirabelli D, Sommani L, Belletti I, Troschel L, Romeo L, Miceli G, Tozzi GA, Mendico I, Vineis P. Occupational exposure to solvents and the risk of lymphomas. Epidemiology. 2006;17:552–61.PubMedGoogle Scholar
  189. 189.
    Costantini AS, Benvenuti A, Vineis P, Kriebel D, Tumino R, Ramazzotti V, Rodella S, Stagnaro E, Crosignani P, Amadori D, Mirabelli D, Sommani L, Belletti I, Troschel L, Romeo L, Miceli G, Tozzi GA, Mendico I, Maltoni SA, Miligi L. Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case-control study. Am J Ind Med. 2008;51:803–11.PubMedGoogle Scholar
  190. 190.
    Cocco P, t’Mannetje A, Fadda D, Melis M, Becker N, de SS, Foretova L, Mareckova J, Staines A, Kleefeld S, Maynadie M, Nieters A, Brennan P, Boffetta P. Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study. Occup Environ Med. 2010;67:341–7.PubMedGoogle Scholar
  191. 191.
    Orsi L, Monnereau A, Dananche B, Berthou C, Fenaux P, Marit G, Soubeyran P, Huguet F, Milpied N, Leporrier M, Hemon D, Troussard X, Clavel J. Occupational exposure to organic solvents and lymphoid neoplasms in men: results of a French case-control study. Occup Environ Med. 2010;67:664–72.PubMedGoogle Scholar
  192. 192.
    Fabbro-Peray P, Daures JP, Rossi JF. Environmental risk factors for non-Hodgkin’s lymphoma: a population-based case-control study in Languedoc-Roussillon, France. Cancer Causes Control. 2001;12:201–12.PubMedGoogle Scholar
  193. 193.
    Fritschi L, Benke G, Hughes AM, Kricker A, Vajdic CM, Grulich A, Turner J, Milliken S, Kaldor J, Armstrong BK. Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia). Cancer Causes Control. 2005;16:599–607.PubMedGoogle Scholar
  194. 194.
    Seidler A, Mohner M, Berger J, Mester B, Deeg E, Elsner G, Nieters A, Becker N. Solvent exposure and malignant lymphoma: a population-based case-control study in Germany. J Occup Med Toxicol. 2007;2:2.PubMedCentralPubMedGoogle Scholar
  195. 195.
    Tranah GJ, Holly EA, Bracci PM. Solvent exposure and non-Hodgkin lymphoma: no risk in a population-based study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev. 2009;18:3130–2.PubMedCentralPubMedGoogle Scholar
  196. 196.
    Wang R, Zhang Y, Lan Q, Holford TR, Leaderer B, Zahm SH, Boyle P, Dosemeci M, Rothman N, Zhu Y, Qin Q, Zheng T. Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol. 2009;169:176–85.PubMedCentralPubMedGoogle Scholar
  197. 197.
    Wong O, Harris F, Armstrong TW, Hua F. A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification. Chem Biol Interact. 2010;184:129–46.PubMedGoogle Scholar
  198. 198.
    Purdue MP, Bakke B, Stewart P, De Roos AJ, Schenk M, Lynch CF, Bernstein L, Morton LM, Cerhan JR, Severson RK, Cozen W, Davis S, Rothman N, Hartge P, Colt JS. A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma. Environ Health Perspect. 2011;119:232–8.PubMedCentralPubMedGoogle Scholar
  199. 199.
    Hayes RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Travis LB, Li CY, Rothman N, Hoover RN, Linet MS. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine–National Cancer Institute Benzene Study Group [see comments]. J Natl Cancer Inst. 1997;89:1065–71.PubMedGoogle Scholar
  200. 200.
    Bond GG, Bodner KM, Olsen GW, Cook RR. Mortality among workers engaged in the development or manufacture of styrene-based products–an update. Scand J Work Environ Health. 1992;18:145–54.PubMedGoogle Scholar
  201. 201.
    Bakke B, Stewart PA, Waters MA. Uses of and exposure to trichloroethylene in U.S. industry: a systematic literature review. J Occup Environ Hyg. 2007;4:375–90.PubMedGoogle Scholar
  202. 202.
    McGregor DB, Heseltine E, Moller H. Dry cleaning, some solvents used in dry cleaning and other industrial chemicals. IARC meeting, Lyon, 7–14 February 1995. Scand J Work Environ Health. 1995;21:310–2.PubMedGoogle Scholar
  203. 203.
    Ward EM, Schulte PA, Straif K, Hopf NB, Caldwell JC, Carreon T, DeMarini DM, Fowler BA, Goldstein BD, Hemminki K, Hines CJ, Pursiainen KH, Kuempel E, Lewtas J, Lunn RM, Lynge E, McElvenny DM, Muhle H, Nakajima T, Robertson LW, Rothman N, Ruder AM, Schubauer-Berigan MK, Siemiatycki J, Silverman D, Smith MT, Sorahan T, Steenland K, Stevens RG, Vineis P, Zahm SH, Zeise L, Cogliano VJ. Research recommendations for selected IARC-classified agents. Environ Health Perspect. 2010;118:1355–62.PubMedCentralPubMedGoogle Scholar
  204. 204.
    Lan Q, Zhang L, Tang X, Shen M, Smith MT, Qiu C, Ge Y, Ji Z, Xiong J, He J, Reiss B, Hao Z, Liu S, Xie Y, Guo W, Purdue MP, Galvan N, Xin KX, Hu W, Beane Freeman LE, Blair AE, Li L, Rothman N, Vermeulen R, Huang H. Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers. Carcinogenesis. 2010;31:1592–6.PubMedCentralPubMedGoogle Scholar
  205. 205.
    Scott CS, Jinot J. Trichloroethylene and cancer: systematic and quantitative review of epidemiologic evidence for identifying hazards. Int J Environ Res Public Health. 2011;8:4238–72.PubMedCentralPubMedGoogle Scholar
  206. 206.
    Hansen J, Raaschou-Nielsen O, Christensen JM, Johansen I, McLaughlin JK, Lipworth L, Blot WJ, Olsen JH. Cancer incidence among Danish workers exposed to trichloroethylene. J Occup Environ Med. 2001;43:133–9.PubMedGoogle Scholar
  207. 207.
    Axelson O, Selden A, Andersson K, Hogstedt C. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J Occup Med. 1994;36:556–62.PubMedGoogle Scholar
  208. 208.
    Anttila A, Pukkala E, Sallmen M, Hernberg S, Hemminki K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med. 1995;37:797–806.PubMedGoogle Scholar
  209. 209.
    Raaschou-Nielsen O, Hansen J, McLaughlin JK, Kolstad H, Christensen JM, Tarone RE, Olsen JH. Cancer risk among workers at Danish companies using trichloroethylene: a cohort study. Am J Epidemiol. 2003;158:1182–92.PubMedGoogle Scholar
  210. 210.
    Barry DM, Carpenter C, Yager C, Golik B, Barry KJ, Shen H, Mikse O, Eggert LS, Schulz DJ, Garcia ML. Variation of the neurofilament medium KSP repeat sub-domain across mammalian species: implications for altering axonal structure. J Exp Biol. 2010;213:128–36.PubMedGoogle Scholar
  211. 211.
    Deng Q, Zheng T, Lan Q, Lan Y, Holford T, Chen Y, Dai M, Leaderer B, Boyle P, Chanock SJ, Rothman N, Zhang Y. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma. Eur J Cancer Prev. 2013;22:77–82.PubMedCentralPubMedGoogle Scholar
  212. 212.
    Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 2006;7:27–38.PubMedGoogle Scholar
  213. 213.
    Jiao J, Zheng T, Lan Q, Chen Y, Deng Q, Bi X, Kim C, Holford T, Leaderer B, Boyle P, Ba Y, Xia Z, Chanock SJ, Rothman N, Zhang Y. Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin’s lymphoma. Eur J Cancer Prev. 2012;21:580–4.PubMedCentralPubMedGoogle Scholar
  214. 214.
    Hansen ES. A follow-up study on the mortality of truck drivers. Am J Ind Med. 1993;23:811–21.PubMedGoogle Scholar
  215. 215.
    Heineman EF, Olsen JH, Pottern LM, Gomez M, Raffn E, Blair A. Occupational risk factors for multiple myeloma among Danish men. Cancer Causes Control. 1992;3:555–68.PubMedGoogle Scholar
  216. 216.
    Boffetta P, Stellman SD, Garfinkel L. A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer. 1989;43:554–9.PubMedGoogle Scholar
  217. 217.
    Howe GR, Lindsay JP. A follow-up study of a ten-percent sample of the Canadian labor force. I. Cancer mortality in males, 1965–73. J Natl Cancer Inst. 1983;70:37–44.PubMedGoogle Scholar
  218. 218.
    Blair A, Zheng T, Linos A, Stewart PA, Zhang YW, Cantor KP. Occupation and leukemia: a population-based case-control study in Iowa and Minnesota. Am J Ind Med. 2001;40:3–14.PubMedGoogle Scholar
  219. 219.
    Holly EA, Lele C. Non-Hodgkin’s lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: allergies, prior medication use, and sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:211–22.PubMedGoogle Scholar
  220. 220.
    Van den Eeden SK, Friedman GD. Exposure to engine exhaust and risk of subsequent cancer. J Occup Med. 1993;35:307–11.Google Scholar
  221. 221.
    Sonoda T, Nagata Y, Mori M, Ishida T, Imai K. Meta-analysis of multiple myeloma and benzene exposure. J Epidemiol. 2001;11:249–54.PubMedGoogle Scholar
  222. 222.
    Flodin U, Fredriksson M, Persson B, Axelson O. Chronic lymphatic leukaemia and engine exhausts, fresh wood, and DDT: a case-referent study. Br J Ind Med. 1988;45:33–8.PubMedCentralPubMedGoogle Scholar
  223. 223.
    Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst. 2003;95:1615–23.PubMedGoogle Scholar
  224. 224.
    Beane Freeman LE, Blair A, Lubin JH, Stewart PA, Hayes RB, Hoover RN, Hauptmann M. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort. J Natl Cancer Inst. 2009;101:751–61.PubMedCentralPubMedGoogle Scholar
  225. 225.
    Hauptmann M, Stewart PA, Lubin JH, Beane Freeman LE, Hornung RW, Herrick RF, Hoover RN, Fraumeni Jr JF, Blair A, Hayes RB. Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde. J Natl Cancer Inst. 2009;101:1696–708.PubMedCentralPubMedGoogle Scholar
  226. 226.
    Stroup NE, Blair A, Erikson GE. Brain cancer and other causes of death in anatomists. J Natl Cancer Inst. 1986;77:1217–24.PubMedGoogle Scholar
  227. 227.
    Hall A, Harrington JM, Aw TC. Mortality study of British pathologists. Am J Ind Med. 1991;20:83–9.PubMedGoogle Scholar
  228. 228.
    Schwilk E, Zhang L, Smith MT, Smith AH, Steinmaus C. Formaldehyde and leukemia: an updated meta-analysis and evaluation of bias. J Occup Environ Med. 2010;52:878–86.PubMedGoogle Scholar
  229. 229.
    Zhang L, Steinmaus C, Eastmond DA, Xin XK, Smith MT. Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms. Mutat Res. 2009;681:150–68.PubMedGoogle Scholar
  230. 230.
    Zhang L, Tang X, Rothman N, Vermeulen R, Ji Z, Shen M, Qiu C, Guo W, Liu S, Reiss B, Freeman LB, Ge Y, Hubbard AE, Hua M, Blair A, Galvan N, Ruan X, Alter BP, Xin KX, Li S, Moore LE, Kim S, Xie Y, Hayes RB, Azuma M, Hauptmann M, Xiong J, Stewart P, Li L, Rappaport SM, Huang H, Fraumeni Jr JF, Smith MT, Lan Q. Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev. 2010;19:80–8.PubMedCentralPubMedGoogle Scholar
  231. 231.
    Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation NRC. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. Washington, D.C.: The National Academies Press; 2006.Google Scholar
  232. 232.
    Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Matsui T. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res. 1994;137:S68–97.PubMedGoogle Scholar
  233. 233.
    Richardson D, Sugiyama H, Nishi N, Sakata R, Shimizu Y, Grant EJ, Soda M, Hsu WL, Suyama A, Kodama K, Kasagi F. Ionizing radiation and leukemia mortality among Japanese atomic bomb survivors, 1950–2000. Radiat Res. 2009;172:368–82.PubMedGoogle Scholar
  234. 234.
    Iwanaga M, Hsu WL, Soda M, Takasaki Y, Tawara M, Joh T, Amenomori T, Yamamura M, Yoshida Y, Koba T, Miyazaki Y, Matsuo T, Preston DL, Suyama A, Kodama K, Tomonaga M. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. J Clin Oncol. 2011;29:428–34.PubMedGoogle Scholar
  235. 235.
    Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn YO, Amoros E, Ashmore P, Auvinen A, Bae JM, Solano JB, Biau A, Combalot E, Deboodt P, Diez Sacristan A, Eklof M, Engels H, Engholm G, Gulis G, Habib R, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (Clin Res Ed). 2005;331:77.Google Scholar
  236. 236.
    Daniels RD, Schubauer-Berigan MK. A meta-analysis of leukaemia risk from protracted exposure to low-dose gamma radiation. Occup Environ Med. 2011;68(6):457–64.Google Scholar
  237. 237.
    Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn YO, Amoros E, Ashmore P, Auvinen A, Bae JM, Bernar J, Biau A, Combalot E, Deboodt P, Diez Sacristan A, Eklöf M, Engels H, Engholm G, Gulis G, Habib RR, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat Res. 2007;167:396–416.PubMedGoogle Scholar
  238. 238.
    Vrijheid M, Cardis E, Ashmore P, Auvinen A, Gilbert E, Habib RR, Malker H, Muirhead CR, Richardson DB, Rogel A, Schubauer-Berigan M, Tardy HÃ, Telle-Lamberton M. Ionizing radiation and risk of chronic lymphocytic leukemia in the 15-country study of nuclear industry workers. Radiat Res. 2008;170:661–5.PubMedCentralPubMedGoogle Scholar
  239. 239.
    Berrington A, Darby SC, Weiss HA, Doll R. 100 years of observation on British radiologists: mortality from cancer and other causes 1897–1997. Br J Radiol. 2001;74:507–19.PubMedGoogle Scholar
  240. 240.
    Linet MS, Freedman DM, Mohan AK, Doody MM, Ron E, Mabuchi K, Alexander BH, Sigurdson A, Hauptmann M. Incidence of haematopoietic malignancies in US radiologic technologists. Occup Environ Med. 2005;62:861–7.PubMedCentralPubMedGoogle Scholar
  241. 241.
    Kheifets L, Renew D, Sias G, Swanson J. Extremely low frequency electric fields and cancer: assessing the evidence. Bioelectromagnetics. 2010;31:89–101.PubMedGoogle Scholar
  242. 242.
    Swanson J, Kheifets L. Biophysical mechanisms: a component in the weight of evidence for health effects of power-frequency electric and magnetic fields. Radiat Res. 2006;165:470–8.PubMedGoogle Scholar
  243. 243.
    Kheifets L, Monroe J, Vergara X, Mezei G, Afifi AA. Occupational electromagnetic fields and leukemia and brain cancer: an update to two meta-analyses. J Occup Environ Med. 2008;50:677–88.PubMedGoogle Scholar
  244. 244.
    Kheifets LI, Afifi AA, Buffler PA, Zhang ZW, Matkin CC. Occupational electric and magnetic field exposure and leukemia. A meta-analysis. J Occup Environ Med. 1997;39:1074–91.PubMedGoogle Scholar
  245. 245.
    Guenel P, Nicolau J, Imbernon E, Chevalier A, Goldberg M. Exposure to 50-Hz electric field and incidence of leukemia, brain tumors, and other cancers among French electric utility workers. Am J Epidemiol. 1996;144:1107–21.PubMedGoogle Scholar
  246. 246.
    Miller AB, To T, Agnew DA, Wall C, Green LM. Leukemia following occupational exposure to 60-Hz electric and magnetic fields among Ontario electric utility workers. Am J Epidemiol. 1996;144:150–60.PubMedGoogle Scholar
  247. 247.
    Karipidis K, Benke G, Sim M, Fritschi L, Yost M, Armstrong B, Hughes AM, Grulich A, Vajdic CM, Kaldor J, Kricker A. Occupational exposure to power frequency magnetic fields and risk of non-Hodgkin lymphoma. Occup Environ Med. 2007;64:25–9.PubMedCentralPubMedGoogle Scholar
  248. 248.
    Sahl JD, Kelsh MA, Greenland S. Cohort and nested case-control studies of hematopoietic cancers and brain cancer among electric utility workers. Epidemiology. 1993;4:104–14.PubMedGoogle Scholar
  249. 249.
    Schroeder JC, Savitz DA. Lymphoma and multiple myeloma mortality in relation to magnetic field exposure among electric utility workers. Am J Ind Med. 1997;32:392–402.PubMedGoogle Scholar
  250. 250.
    Theriault G, Goldberg M, Miller AB, Armstrong B, Guénel P, Deadman J, Imbernon E, To T, Chevalier A, Cyr D. Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970–1989. Am J Epidemiol. 1994;139:550–72.PubMedGoogle Scholar
  251. 251.
    Villeneuve PJ, Agnew DA, Miller AB, Corey PN. Non-Hodgkin’s lymphoma among electric utility workers in Ontario: the evaluation of alternate indices of exposure to 60 Hz electric and magnetic fields. Occup Environ Med. 2000;57:249–57.PubMedCentralPubMedGoogle Scholar
  252. 252.
    Hakansson N, Floderus B, Gustavsson P, Johansen C, Olsen JH. Cancer incidence and magnetic field exposure in industries using resistance welding in Sweden. Occup Environ Med. 2002;59:481–6.PubMedCentralPubMedGoogle Scholar
  253. 253.
    Milham SJ. Mortality in workers exposed to electromagnetic fields. Environ Health Perspect. 1985;62:297–300.PubMedCentralPubMedGoogle Scholar
  254. 254.
    Roosli M, Lortscher M, Egger M, Pfluger D, Schreier N, Lortscher E, Locher P, Spoerri A, Minder C. Leukaemia, brain tumours and exposure to extremely low frequency magnetic fields: cohort study of Swiss railway employees. Occup Environ Med. 2007;64:553–9.PubMedCentralPubMedGoogle Scholar
  255. 255.
    Tynes T, Haldorsen T. Residential and occupational exposure to 50 Hz magnetic fields and hematological cancers in Norway. Cancer Causes Control. 2003;14:715–20.PubMedGoogle Scholar
  256. 256.
    Some organic solvents, resin monomers and related compounds, pigments and occupational exposures in paint manufacture and painting. IARC Monogr Eval Carcinog Risks Hum. 1989;47:1–442.Google Scholar
  257. 257.
    Kato I, Koenig KL, Watanabe-Meserve H, Baptiste MS, Lillquist PP, Frizzera G, Burke JS, Moseson M, Shore RE. Personal and occupational exposure to organic solvents and risk of non-Hodgkin’s lymphoma (NHL) in women (United States). Cancer Causes Control. 2005;16:1215–24.PubMedGoogle Scholar
  258. 258.
    McLaughlin JK, Malker HS, Linet MS, Ericsson J, Stone BJ, Weiner J, Blot WJ, Fraumeni JFJ. Multiple myeloma and occupation in Sweden. Arch Environ Health. 1988;43:7–10.PubMedGoogle Scholar
  259. 259.
    Andersen A, Barlow L, Engeland A, Kjaerheim K, Lynge E, Pukkala E. Work-related cancer in the Nordic countries. Scand J Work Environ Health. 1999;25 Suppl 2:1–116.PubMedGoogle Scholar
  260. 260.
    Steenland K, Palu S. Cohort mortality study of 57,000 painters and other union members: a 15 year update. Occup Environ Med. 1999;56:315–21.PubMedCentralPubMedGoogle Scholar
  261. 261.
    Brown LM, Moradi T, Gridley G, Plato N, Dosemeci M, Fraumeni Jr JF. Exposures in the painting trades and paint manufacturing industry and risk of cancer among men and women in Sweden. J Occup Environ Med. 2002;44:258–64.PubMedGoogle Scholar
  262. 262.
    Chen R, Seaton A. A meta-analysis of painting exposure and cancer mortality. Cancer Detect Prev. 1998;22:533–9.PubMedGoogle Scholar
  263. 263.
    Blair A, Linos A, Stewart PA, Burmeister LF, Gibson R, Everett G, Schuman L, Cantor KP. Evaluation of risks for non-Hodgkin’s lymphoma by occupation and industry exposures from a case-control study. Am J Ind Med. 1993;23:301–12.PubMedGoogle Scholar
  264. 264.
    Dryver E, Brandt L, Kauppinen T, Olsson H. Occupational exposures and non-Hodgkin’s lymphoma in Southern Sweden. Int J Occup Environ Health. 2004;10:13–21.PubMedGoogle Scholar
  265. 265.
    Cuzick J, De Stavola B. Multiple myeloma–a case-control study. Br J Cancer. 1988;57:516–20.PubMedCentralPubMedGoogle Scholar
  266. 266.
    Friedman GD. Multiple myeloma: relation to propoxyphene and other drugs, radiation and occupation. Int J Epidemiol. 1986;15:424–6.PubMedGoogle Scholar
  267. 267.
    Morris PD, Koepsell TD, Daling JR, Taylor JW, Lyon JL, Swanson GM, Child M, Weiss NS. Toxic substance exposure and multiple myeloma: a case-control study. J Natl Cancer Inst. 1986;76:987–94.PubMedGoogle Scholar
  268. 268.
    Pasqualetti P, Casale R, Collacciani A, Colantonio D. Work activities and the risk of multiple myeloma. A case-control study. Med Lav. 1990;81:308–19.PubMedGoogle Scholar
  269. 269.
    Pearce NE, Howard JK. Occupation, social class and male cancer mortality in New Zealand, 1974–78. Int J Epidemiol. 1986;15:456–62.PubMedGoogle Scholar
  270. 270.
    Mele A, Szklo M, Visani G, Stazi MA, Castelli G, Pasquini P, Mandelli F. Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study Group. Am J Epidemiol. 1994;139:609–19.PubMedGoogle Scholar
  271. 271.
    Delzell E, Sathiakumar N, Graff J, Macaluso M, Maldonado G, Matthews R. An updated study of mortality among North American synthetic rubber industry workers. Res Rep Health Eff Inst. 2006;132:1–63.Google Scholar
  272. 272.
    Andjelkovich D, Taulbee J, Symons M, Williams T. Mortality of rubber workers with reference to work experience. J Occup Med. 1977;19:397–405.PubMedGoogle Scholar
  273. 273.
    Wilczynska U, Szadkowska-Stanczyk I, Szeszenia-Dabrowska N, Sobala W, Strzelecka A. Cancer mortality in rubber tire workers in Poland. Int J Occup Med Environ Health. 2001;14:115–25.PubMedGoogle Scholar
  274. 274.
    Dost A, Straughan J, Sorahan T. A cohort mortality and cancer incidence survey of recent entrants (1982–91) to the UK rubber industry: findings for 1983–2004. Occup Med (Lond). 2007;57:186–90.Google Scholar
  275. 275.
    Sorahan T, Parkes HG, Veys CA, Waterhouse JA, Straughan JK, Nutt A. Mortality in the British rubber industry 1946–85. Br J Ind Med. 1989;46:1–10.PubMedCentralPubMedGoogle Scholar
  276. 276.
    Gustavsson P, Hogstedt C, Holmberg B. Mortality and incidence of cancer among Swedish rubber workers, 1952–1981. Scand J Work Environ Health. 1986;12:538–44.PubMedGoogle Scholar
  277. 277.
    McMichael AJ, Andjelkovic DA, Tyroler HA. Cancer mortality among rubber workers: an epidemiologic study. Ann N Y Acad Sci. 1976;271:125–37.PubMedGoogle Scholar
  278. 278.
    Steenland K, Stayner L, Deddens J. Mortality analyses in a cohort of 18 235 ethylene oxide exposed workers: follow up extended from 1987 to 1998. Occup Environ Med. 2004;61:2–7.PubMedCentralPubMedGoogle Scholar
  279. 279.
    Coggon D, Harris EC, Poole J, Palmer KT. Mortality of workers exposed to ethylene oxide: extended follow up of a British cohort. Occup Environ Med. 2004;61:358–62.PubMedCentralPubMedGoogle Scholar
  280. 280.
    King AS, Threlfall WJ, Band PR, Gallagher RP. Mortality among female registered nurses and school teachers in British Columbia. Am J Ind Med. 1994;26:125–32.PubMedGoogle Scholar
  281. 281.
    Rix BA, Lynge E. Cancer incidence in Danish health care workers. Scand J Soc Med. 1996;24:114–20.PubMedGoogle Scholar
  282. 282.
    Skov T, Maarup B, Olsen J, Rorth M, Winthereik H, Lynge E. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med. 1992;49:855–61.PubMedCentralPubMedGoogle Scholar
  283. 283.
    Petralia SA, Dosemeci M, Adams EE, Zahm SH. Cancer mortality among women employed in health care occupations in 24 U.S. states, 1984–1993. Am J Ind Med. 1999;36:159–65.PubMedGoogle Scholar
  284. 284.
    Williams RR, Stegens NL, Goldsmith JR. Associations of cancer site and type with occupation and industry from the Third National Cancer Survey Interview. J Natl Cancer Inst. 1977;59:1147–85.PubMedGoogle Scholar
  285. 285.
    Miligi L, Seniori CA, Crosignani P, Fontana A, Masala G, Nanni O, Ramazzotti V, Rodella S, Stagnaro E, Tumino R, Vigano C, Vindigni C, Vineis P. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med. 1999;36:60–9.PubMedGoogle Scholar
  286. 286.
    Baker P, Inskip H, Coggon D. Lymphatic and hematopoietic cancer in teachers. Scand J Work Environ Health. 1999;25:5–17.PubMedGoogle Scholar
  287. 287.
    Guidotti TL. Evaluating causality for occupational cancers: the example of firefighters. Occup Med (Lond). 2007;57:466–71.Google Scholar
  288. 288.
    Howe GR, Burch JD. Fire fighters and risk of cancer: an assessment and overview of the epidemiologic evidence. Am J Epidemiol. 1990;132:1039–50.PubMedGoogle Scholar
  289. 289.
    Baris D, Garrity T, Telles JL, Heineman EF, Olshan A, Zahm SH. A cohort mortality study of Philadelphia firefighters. Am J Ind Med. 2001;39:463–76.PubMedGoogle Scholar
  290. 290.
    Demers PA, Heyer NJ, Rosenstock L. Mortality among firefighters from three northwestern United States cities. Br J Ind Med. 1992;49:664–70.PubMedCentralPubMedGoogle Scholar
  291. 291.
    Beaumont JJ, Chu GS, Jones JR, Schenker MB, Singleton JA, Piantanida LG, Reiterman M. An epidemiologic study of cancer and other causes of mortality in San Francisco firefighters. Am J Ind Med. 1991;19:357–72.PubMedGoogle Scholar
  292. 292.
    Vena JE, Fiedler RC. Mortality of a municipal-worker cohort: IV. Fire fighters. Am J Ind Med. 1987;11:671–84.PubMedGoogle Scholar
  293. 293.
    Delzell E, Grufferman S. Cancer and other causes of death among female textile workers, 1976–78. J Natl Cancer Inst. 1983;71:735–40.PubMedGoogle Scholar
  294. 294.
    Fritschi L, Siemiatycki J. Lymphoma, myeloma and occupation: Results of a case-control study. Int J Cancer. 1996;67:498–503.PubMedGoogle Scholar
  295. 295.
    Linet MS, McLaughlin JK, Malker HS, Chow WH, Weiner JA, Stone BJ, Ericsson JL, Fraumeni JFJ. Occupation and hematopoietic and lymphoproliferative malignancies among women: a linked registry study. J Occup Med. 1994;36:1187–98.PubMedGoogle Scholar
  296. 296.
    Spinelli JJ, Gallagher RP, Band PR, Threlfall WJ. Multiple myeloma, leukemia, and cancer of the ovary in cosmetologists and hairdressers. Am J Ind Med. 1984;6:97–102.PubMedGoogle Scholar
  297. 297.
    Boffetta P, Andersen A, Lynge E, Barlow L, Pukkala E. Employment as hairdresser and risk of ovarian cancer and non-Hodgkin’s lymphomas among women. J Occup Med. 1994;36:61–5.PubMedGoogle Scholar
  298. 298.
    Takkouche B, Regueira-Mendez C, Montes-Martinez A. Risk of cancer among hairdressers and related workers: a meta-analysis. Int J Epidemiol. 2009;38:1512–31.PubMedGoogle Scholar
  299. 299.
    Robinson CF, Walker JT. Cancer mortality among women employed in fast-growing U.S. occupations. Am J Ind Med. 1999;36:186–92.PubMedGoogle Scholar
  300. 300.
    Preston-Martin S, Peters JM. Prior employment as a welder associated with the development of chronic myeloid leukaemia. Br J Cancer. 1988;58:105–8.PubMedCentralPubMedGoogle Scholar
  301. 301.
    Persson B, Fredriksson M, Olsen K, Boeryd B, Axelson O. Some occupational exposures as risk factors for malignant lymphomas. Cancer. 1993;72:1773–8.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Department of Occupational and Environmental HealthSchool of Public Health, Drexel UniversityPhiladelphiaUSA
  2. 2.Program in Epidemiology, Division of Public Health SciencesFred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations